Full Name
En Zuo Conrad Chan
(not current staff)
Main Affiliation
 
 
Email
lsiccez@nus.edu.sg
 

Publications

Results 1-7 of 7 (Search time: 0.005 seconds).

Issue DateTitleAuthor(s)
121-Oct-2022Defining the specificity and function of a human neutralizing antibody for Hepatitis B virusJhajharia, Saket ; Lai, Fritz ; Low, Heng Boon ; Purushotorman, Kiren ; Shunmuganathan, Bhuvaneshwari Do ; Chan, Conrad En Zuo ; Hammond, Rachel; Netter, Hans-Juergen; Chen, Qingfeng ; Lim, Seng Gee ; MacAry, Paul A 
22008Epitope characterization of the protective monoclonal antibody VN4-2 shows broadly neutralizing activity against highly pathogenic H5N1Lim A.P.C. ; Wong S.K.K.; Chan A.H.Y.; Chan C.E.Z. ; Ooi E.E. ; Hanson B.J. 
32012Generation and characterization of a novel recombinant antibody against 15-ketocholestane isolated by phage-displayOmedul Islam M. ; Lim Y.T. ; Chan C.E.Z. ; Cazenave-Gassiot A. ; Ludovic Croxford J. ; Wenk M.R. ; Macary P.A. ; Hanson B.J. 
64417-Aug-2022IDentif.AI-Omicron: Harnessing an AI-Derived and Disease-Agnostic Platform to Pinpoint Combinatorial Therapies for Clinically Actionable Anti-SARS-CoV-2 InterventionBlasiak, Agata ; Truong, Anh TL ; Wang, Peter; Hooi, Lissa ; Chye, De Hoe; Tan, Shi-Bei; You, Kui; Remus, Alexandria ; Allen, David Michael ; Chai, Louis Yi Ann ; Chan, Conrad EZ ; Lye, David CB ; Tan, Gek-Yen G; Seah, Shirley GK; Chow, Edward Kai-Hua ; Ho, Dean 
645Jan-2021IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) with digital drug developmentBlasiak, Agata ; Lim, Jhin Jieh ; Seah, Shirley Gek Kheng; Kee, Theodore ; Remus, Alexandria ; Chye, De Hoe; Wong, Pui San; Hooi, Lissa ; Truong, Anh TL ; Le, Nguyen ; Chan, Conrad EZ ; Desai, Rishi ; Ding, Xianting; Hanson, Brendon J ; Chow, Edward Kai-Hua ; Ho, Dean 
6462008Neutralizing human monoclonal antibody against H5N1 influenza HA selected from a Fab-phage display libraryLim A.P.C. ; Chan C.E.Z. ; Wong S.K.K.; Chan A.H.Y.; Ooi E.E. ; Hanson B.J. 
6472017TCR-like antibodies mediate complement and antibody-dependent cellular cytotoxicity against Epstein-Barr virus-transformed B lymphoblastoid cells expressing different HLA-A?02 microvariantsLai J.; Choo J.A.L. ; Tan W.J. ; Too C.T. ; Oo M.Z. ; Suter M.A. ; Mustafa F.B. ; Srinivasan N. ; Chan C.E.Z. ; Lim A.G.X.; Zhong Y. ; Chan S.H. ; Hanson B.J. ; Gascoigne N.R.J. ; MacAry P.A.